GlassScriptPhysician profile
Gregory K Yim
NPI 1922191725
$3,080.73
in general payments reported to CMS, 2019-2025
16 companies · $697 in 2025
The $697 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.85 · 2020: $55.80 · 2021: $86.52 · 2022: $201 · 2023: $263 · 2024: $1,733 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,937 · Travel and Lodging: $755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,937.44 |
| Travel and Lodging | $754.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,423.51 | 2020-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Neurelis, INC. | $670.84 | 2020-2025 | Valtoco |
| Ucb, INC. | $210.90 | 2019-2025 | Fintepla |
| Regeneron Healthcare Solutions, INC. | $134.99 | 2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $99.11 | 2022-2025 | |
| Sarepta Therapeutics, INC. | $77.38 | 2023-2025 | Elevidys |
| Alexion Pharmaceuticals, INC. | $73.67 | 2023-2024 | Koselugo |
| Acadia Pharmaceuticals INC | $69.82 | 2024-2025 | Daybue |
| Biogen, INC. | $69.34 | 2022-2024 | Spinraza, Skyclarys |
| Immedica Pharma US, INC. | $63.74 | 2024 | |
| Itf Therapeutics LLC | $63.48 | 2025 | |
| Allergan, INC. | $36.64 | 2019-2020 | |
| Biocodex, INC. | $30.53 | 2025 | |
| Eisai INC. | $24.59 | 2021 | |
| Corium, LLC | $22.76 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $9.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Yim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.